ClinicalTrials.gg
CompletedNCT05962411Updated Aug 6, 2024

Effects of Dress by Adolescents on Electronic Cigarette Retailer Behaviors in China

An interventional study of Dress in Professional Attire in Regulation Compliance and Electronic Nicotine Delivery Systems, sponsored by Peking University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2024-08-06.

Sponsored by Peking University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,089
Allocation
Randomized
Sex
All
01

Study summary

This study is a national-level randomized control trial to measure the effects of dressing in professional attire by adolescents on regulation compliance-related behaviors of electronic cigarette (e-cigarette) retailers defined by both age verification and potential underage sales. The corresponding null hypothesis that will be tested is that dressing in professional attire by adolescents will have no effect upon retailer behaviors in regulation compliance. The secondary objectives are to determine the impacts of type of dress by adolescents on marketing and communication strategies adopted by retailers, as well as to document the differences in the behaviors between e-cigarette and tobacco retailers.

Read the detailed description

Electronic cigarette (e-cigarette) use has been growing dramatically and poses a significant public health threat to adolescents in China. After the online sales of these products has been banned, purchases from brick-and-mortar stores became the only legal option for the users. However, little research has been conducted to document sales behaviors of the physical retailers and identify the associated factors. The study will investigate the extent to which dressing in professional attire by adolescents on regulation compliance in retailer behaviors, including inquiring about age, requesting identity cards for age verification, and completing transactions even when identity cards are not presented. Adopting the simulated client method, the study will collect information on regulation compliance, store environment, product availability, and marketing strategies through interacting with retailers across China. Considering that e-cigarette retailers are predominately located in the most densely populated cities, the investigators will include approximately 1,080 e-cigarette retailers from 36 cities, including 4 municipalities directly under the Central Government, 27 provincial capital cities, and 5 cities specially designated in the state plan. Store addresses and contact information will be obtained through web scraping from the AutoNavi map (the most popular map app in China). The investigators plan to randomly sample 32 retailers in each city if the number allows, and cities with less than 32 retailers identified will all be included. To capture reality, retailers will not be informed during visit. The sampled ones within each city will be randomized into the intervention and control group, with a balance gender ratio of the simulated clients. These clients will be recruited from university students younger than 20 years old, who can easily be considered as minors (under 18) when purely judged by their appearance. Clients visiting retailers in the control group will dress in school uniforms and carry a school bag, while those in the intervention group will dress in professional attire with a business-style backpack for males or a leather bag for females. The clients will record retailer responses, including (1) inquiring about age verbally, (2) requesting identity cards for age verification, and (3) whether retailers still sell products even when identity cards are not presented. For each e-cigarette retailer, the nearest tobacco retailer identified through the AutoNavi Map will be used for comparison to document the differences in the behaviors between the two types of retailers. Additionally, communication and marketing strategies, e.g., mentioning available flavored products, dissuading clients not to purchase, are also collected.

02

Conditions studied

  • Regulation Compliance
  • Electronic Nicotine Delivery Systems

Browse trials for

Keywords

  • Electronic Cigarette
  • Retailer
  • Adolescent
  • Regulation Compliance
  • China
03

In context

Vaping

172 studies on the registry are indexed under Vaping; 74 are open to participants now.

This study's enrollment of 1,089 is above the median of 104 across 144 interventional studies indexed under Vaping.

Browse Vaping studies →

Lead sponsor

Peking University is the lead sponsor of 418 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Retailers can be identified from the AutoNavi Map through keyword searches
  • Retailers have reachable contact information
  • Retailers are contacted and claim being open for business on a regular basis
  • Include only one retailer if multiple ones have the same contact information

Exclusion criteria

Exclusion Criteria:

  • Retailers that are not located in main districts of the cities (usually old town and economically developed central areas)
  • Perceived danger surrounding the retailers (e.g., remote alleys with no pedestrians at all)
  • Closed when arriving
  • Retailers that cannot be located based on map information
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,089 participants (actual)

Study arms

  • No intervention
    Dress in School Uniforms

    Simulated clients dress in school uniforms, enter e-cigarette stores, and act as minor buyers.

  • Experimental
    Dress in Professional Attire

    Simulated clients dress in business casuals, enter e-cigarette stores, and act as potential "adult e-cigarette buyers".

    Other: Dress in Professional Attire

Interventions

  • OtherDress in Professional Attire

    "Adolescents" pretend to be "adult e-cigarette buyers" by dressing in professional attire.

06

What researchers measure

Primary outcomes

  1. Non-compliant sales

    The simulated clients will report whether retailers sell e-cigarette products to possible minors even when identity cards are not presented for age verification.

    Time frame: During visit (day 1)

Secondary outcomes

  1. Inquiring about age

    The simulated clients will report whether retailers inquire about their age verbally in stores.

    Time frame: During visit (day 1)

  2. Requesting identity cards

    The simulated clients will report whether retailers request them to show identity cards for the purpose of age verification.

    Time frame: During visit (day 1)

Other outcomes

  1. Online contact

    The simulated clients will report if they are able to add retailers as WeChat (the online most popular chat app in China) contacts.

    Time frame: During visit (day 1)

  2. Delivery service offered

    The simulated clients will report if salespersons mention that products ordered online can be delivered to them.

    Time frame: During visit (day 1)

  3. Illegal flavored e-cigarette products available

    The simulated clients will report if salespersons mention that flavored (non-national-standard) e-cigarette products are available in stores.

    Time frame: During visit (day 1)

07

Study locations

1 site
  • 36 major metropolitan areas (Beijing included)
    Beijing, Beijing Municipality 100191, China
08

References and documents

Publications

  • Wang Y, Lv X, Laestadius LI, Guidry JPD, Mahmoudi E, Kong G, Chang J, Martin A, Yang M, Yan D, Si L, Bustamante AV, Fang H. E-Cigarette Sales to School-Uniformed Adolescents in China: A Randomized Clinical Trial. JAMA Netw Open. 2025 Oct 1;8(10):e2535623. doi: 10.1001/jamanetworkopen.2025.35623. PubMed 41071555 ↗

Study documents

  • Study protocol · Jul 27, 2023
  • Statistical analysis plan · Sep 3, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Analytic code

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in Sep 2023, 1 month.

Of 102 non-industry interventional studies with no phase under Vaping, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's 1 month is below that.

Counting every sponsor, half of 103 studies reached it within 18 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2023
First posted
Jul 27, 2023
StartActual
Jul 29, 2023
Primary completionActual
Sep 3, 2023
CompletionActual
Sep 3, 2023
Last update
Aug 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05962411
Lead sponsor
Peking University
Collaborators
China Medical Board
Responsible party
Sponsor
First posted
Jul 27, 2023
Start date
Jul 29, 2023
Primary completion
Sep 3, 2023
Completion
Sep 3, 2023
Last update
Aug 6, 2024

Study contacts

Yang Wang, PhD
principal investigator · Peking University Health Science Center
Hai Fang, PhD
principal investigator · Peking University Health Science Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion